12,372 trials
Atrial Fibrillation · Atrial Flutter
Primary: Number of Participants With First Event of Ischemic/Unspecified Stroke, Hemorrhagic Stroke, or Systemic Embolism (SE) During the Intended Treatment Period — 159; 173…
Short Bowel Syndrome
Primary: Number of Subjects Achieving a 20% Reduction at Week 28 — 5; 3; 17; 14 Participants
Breast Cancer
Primary: Percentage of Participants With PD or Death as Assessed by an Independent Review Committee (IRC) — 53.5; 61.3 percentage of participants
Chronic Obstructive Pulmonary Disease (COPD)
Primary: Percentage of Patients Who Prefer Genuair Device Versus Handihaler Device at Visit 2 — 68.6; 18.1; 13.3 Percentage of Patients
Anesthesia · Neuromuscular Blockade
Primary: Time From Start of Administration of Investigational Medicinal Product (IMP, Sugammadex or Placebo) to Recovery of the Fourth Twitch/First Twitch (T4/T1) Ratio to 0.9…
Severe Hemophilia A
Primary: Efficacy Assessment After a Total of at Least 50 EDs Per Subject at the End of the Study at 6 Months — 0.188 Bleeds per month
Necator Americanus Infection
Primary: Cure Rate — 16.3; 28.3; 18.8 percentage of participants
Critically Ill
Primary: Documented Infection Rate — 58; 41 Infections
HIV-1 Infection
Primary: Percentage of Participants With HIV-1 RNA < 50 Copies/mL at Week 24 (FDA Snapshot Analysis) — 93.7; 89.9 percentage of participants
Hepatitis C, Chronic
Primary: The Percentage of Participants Achieving a Sustained Virologic Response (SVR) 24 Weeks After the Last Dose of Study Drug (SVR24 Actual) — 34.4; 72.7; 81.5; 44.4…
Huntington Disease
Primary: Change From Baseline to Month 18 in the Total Functional Capacity (TFC) Scale [LOCF Imputation Method] — 1.55; 1.15 units on a scale
Pressure Ulcers
Primary: Incidence of Pressure Ulcer (PU) Grade ≥ II — 22; 17 participants
Adenocarcinoma of the Prostate · Hormone-resistant Prostate Cancer · Recurrent Prostate Cancer
Primary: Overall Survival — 21.5; 22.6 months — p=0.181
Type 2 Diabetes Mellitus
Primary: Mean Change From Baseline in A1C at Month 6 — 8.14; 7.96; 7.90; -1.61 percent
Heartburn
Primary: Percentage of Heartburn Free 24 Hour Days During 14 Days of Randomized Treatment — 46.79; 30.93 Percentage of heartburn free days